Cancer Research

Epistem Plc And AstraZeneca Complete Plucked Hair Biomarker Study For Oncology Drug Development

MANCHESTER, England, February 5 /PRNewswire/-- Epistem plc (LSE:EHP) announced today that it had successfully completed a preliminary study with AstraZeneca for the use of its proprietary, minimally invasive plucked human hair biomarker technology to help ...

Article - Anna Ohlden - Feb 5 2008 - 7:31am

ICCVAM Proposes New Plan To Recommend Alternatives To Animal Testing

A new plan to further reduce, refine and replace the use of animals in research and regulatory testing, commonly referred to as the 3Rs, was unveiled today by the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). Traditi ...

Article - News Staff - Feb 5 2008 - 2:35pm

For Antioxidants, Cheap Mushrooms Are As Good As Maitake

Antioxidants are believed to help ward off illness and boost the body’s immune system by acting as free radical scavengers, helping to mop up cell damage caused by free radicals. But you don't have to pay a lot; the humble white button mushroom (Agari ...

Article - News Staff - Feb 6 2008 - 2:07am

ProMetic Provides Business Update- Over CAD$35 Million Worth Of Business Secured In January

MONTREAL, Canada, February 6 /PRNewswire/--- Shipment of Prion Capture Resin to MacoPharma in Q1 2008;- MacoPharma Increased its Forecast for P-Capt(R) Filters Sale in 2008;- Use of Affinity Prion Adsorbent for Plasma-Derived Products to Generate in Exces ...

Article - Anna Ohlden - Feb 6 2008 - 5:31pm

Bone Marrow Stem Cell Release Regulated By Brain’s Biological Clock

Mount Sinai researchers have discovered that the release of blood stem cells from bone marrow is regulated by the brain through the cyclical human biological clock, via adrenergic signals transmitted by the sympathetic nervous system. These new findings, p ...

Article - News Staff - Feb 7 2008 - 10:36am

Interview With Gary Taubes (part 7)

Continued from Part 6: I interviewed Gary Taubes by phone a few weeks ago, shortly after he gave a talk about the main ideas of his new book — Good Calories, Bad Calories — at UC Berkeley. The interview lasted about 2 hours. This is part 7. SETH ROBERTS: ...

Article - Seth Roberts - Feb 7 2008 - 10:46am

Mapped: Network Of Human–Pathogen Protein Interactions

Researchers have provided the first global analysis of human proteins interacting with proteins of viruses and other pathogens. The network of interactions, described in an article published February 15 in the open-access journal PLoS Pathogens, reveals po ...

Article - News Staff - Feb 15 2008 - 1:31am

Helsinn Healthcare SA Announces The Launch Of Aloxi(R) (Palonosetron) In The UK

LUGANO, Switzerland, February 11 /PRNewswire/-- Helsinn Healthcare SA, a Swiss pharmaceutical group, is pleased to announce, ahead of schedule, today's launch in the UK of Aloxi(R) (Palonosetron hydrochloride), a new generation treatment for chemothe ...

Article - Anna Ohlden - Feb 11 2008 - 5:31am

Cancer Pioneer Reaches Key Agreement On Colon Cancer Drug OncoVAX(R)

FREDERICK, Maryland, February 11 /PRNewswire/-- Cancer research pioneer Michael G. Hanna Jr. Ph.D., also Vaccinogen, Inc.'s Founder, Chairman and CEO has acquired the rights to OncoVAX(R), a vaccine with the potential to prevent colon cancer from rec ...

Article - Anna Ohlden - Feb 11 2008 - 3:31pm

Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.

CAMBRIDGE, Massachusetts, February 12 /PRNewswire/-- Mersana, a cancer therapeutics company, announced today that Timothy B. Lowinger, Ph.D., has joined the company as Chief Scientific Officer. "We are thrilled that Tim is now a part of the Mersana t ...

Article - Anna Ohlden - Feb 12 2008 - 7:31am